Gene-Guided reflux drug shows promise for kids with uncontrolled asthma
NCT ID NCT03015610
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 27 times
Summary
This study looked at 41 children aged 6-17 with both mild acid reflux and uncontrolled asthma. Researchers tested whether adjusting the dose of a common reflux medicine (lansoprazole) based on each child's genes could improve asthma control and reduce reflux symptoms. The goal was to see if personalized dosing leads to better outcomes than standard treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
-
Nemours Children's Specialty Care
Jacksonville, Florida, 32207, United States
Conditions
Explore the condition pages connected to this study.